These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21266621)

  • 1. Adding a psychosocial intervention to antipsychotic medication reduces treatment discontinuation and relapse.
    Mortimer AM
    Evid Based Ment Health; 2011 Feb; 14(1):24. PubMed ID: 21266621
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
    Miller BJ
    J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
    Wyatt RJ; Damiani LM; Henter ID
    Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection.
    Lee SH; Choi TK; Suh S; Kim YW; Kim B; Lee E; Yook KH
    Psychiatry Res; 2010 Feb; 175(3):195-9. PubMed ID: 20022120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy of persons with schizophrenia.
    Carpenter WT
    J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis.
    Vanelli M; Coca-Perraillon M; Troxell-Dorgan A
    Clin Ther; 2007 Dec; 29(12):2768-73. PubMed ID: 18201595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
    Woggon B; Bickel P; Schnyder B
    Int Pharmacopsychiatry; 1979; 14(5):278-93. PubMed ID: 43849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive antipsychotic treatment of adolescents with bipolar psychosis.
    Kafantaris V; Coletti DJ; Dicker R; Padula G; Kane JM
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1448-56. PubMed ID: 11765291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the combination of psychosocial and pharmacological treatment in schizophrenic patients].
    Valencia Collazos M; Ortega Soto HA; Rascón Gasca ML; Gómez Caudillo L
    Actas Esp Psiquiatr; 2002; 30(6):358-69. PubMed ID: 12487946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication.
    Saksa JR; Baker CB; Woods SW
    Gen Hosp Psychiatry; 2004; 26(3):233-6. PubMed ID: 15121352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].
    Woggon B
    Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antipsychotic medications.
    Perkins DO
    J Clin Psychiatry; 1999; 60 Suppl 21():25-30. PubMed ID: 10548139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
    Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J
    Med Hypotheses; 2006; 67(3):517-23. PubMed ID: 16632226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.